The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase 1 multicenter, open-label, dose-escalation and dose-expansion study to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, immunogenicity, and antitumor activity of MEDI7247 in patients with select relapsed/refractory hematologic malignancies.
 
Amir Tahmasb Fathi
Honoraria - Agios; Baxalta; Merck; Seagen; Tolero Pharmaceuticals
Research Funding - Celgene (Inst); Exelixis (Inst); Seagen (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - Agios
 
William Bruce Donnellan
No Relationships to Disclose
 
Roger M. Lyons
Employment - Texas Oncology; US Oncology
Honoraria - Celgene; Incyte
Consulting or Advisory Role - Celgene; Incyte
 
Michael B. Maris
No Relationships to Disclose
 
Tae Min Kim
No Relationships to Disclose
 
Won Seog Kim
No Relationships to Disclose
 
Gary J. Schiller
Research Funding - MedImmune
 
Camille N. Abboud
Stock and Other Ownership Interests - Abbott Laboratories (I); Abbvie (I); Gilead Sciences (I); Merck (I)
Honoraria - Agios; Novartis; Pfizer
Consulting or Advisory Role - Gerson Lehrman Group
Speakers' Bureau - Jazz Pharmaceuticals
Research Funding - Cellerant (Inst); Merck (Inst); Novartis (Inst); Novartis (Inst); Pfizer (Inst)
 
Martha Lucia Arellano
Research Funding - Cephalon (Inst)
 
Elizabeth H. Cull
Consulting or Advisory Role - Cellectar
Speakers' Bureau - Celgene
 
Karen W. L. Yee
Consulting or Advisory Role - Celgene; Novartis; Otsuka; Pfizer; Shire
Research Funding - Agensys; Astex Pharmaceuticals; GlaxoSmithKline; Merck; Millennium; Onconova Therapeutics; Roche; Roche/Genentech
 
Danielle Michelle Townsley
Employment - MedImmune
 
Fujun Wang
Employment - AstraZeneca
Stock and Other Ownership Interests - AstraZeneca
 
John G. Bothos
Employment - MedImmune
Stock and Other Ownership Interests - MedImmune
Travel, Accommodations, Expenses - MedImmune
 
Nai-Shun Yao
Employment - AstraZeneca; MedImmune
Stock and Other Ownership Interests - AstraZeneca; Gilead Sciences; MedImmune
 
Gilles A. Salles
Honoraria - Amgen; Bristol-Myers Squibb; Celgene; Gilead Sciences; Gilead Sciences; Janssen; Novartis; Roche/Genentech; SERVIER
Consulting or Advisory Role - Acerta Pharma; Bristol-Myers Squibb; Celgene; Gilead Sciences; Janssen; Kite, a Gilead company; Merck; Novartis; Novimmune; Pfizer; Roche/Genentech; SERVIER
Research Funding - Celgene; Gilead Sciences; Merck; Roche/Genentech; Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Roche/Genentech; Sanofi